Skip to content
Canadian orders above $200 ship free · Dispatched from Canadian stock

Buy NAD+ in Canada

NAD+ in Canada

NAD+ as lyophilised powder in 500 mg and 1000 mg vials. HPLC testing is run on every batch, and it ships from Canadian stock. For laboratory research use only.

Format
Size
$46.50$0.09/mg
Dispatched from Canadian stock

Buy more, pay less per vial

Add 2 more to save 4%

Frequently bought together

At a glance
Also known as
NAD · Nicotinamide adenine dinucleotide · β-NAD+
Class
Redox coenzyme (dinucleotide), not a peptide
Form
Lyophilised powder, 500 mg and 1000 mg vials
Sizes
500 mg · 1 g
Storage, dry
−20 °C, dry and dark
Storage, mixed
2–8 °C once in solution, use within 28 days (as generally reported for reconstituted research materials)
BAC water per size
500 mg: 10 mL · 1000 mg: 10 mL
Molecular weight
663.4 g/mol (NAD+, C21H27N7O14P2)

What is NAD+?

NAD+ is a redox coenzyme (dinucleotide), not a peptide, with a molecular weight of 663.4 g/mol (NAD+, C21H27N7O14P2). Several spellings in the literature point to the same material, among them NAD, Nicotinamide adenine dinucleotide and β-NAD+. Its recorded structure is not a peptide; two nucleotides (nicotinamide and adenine) joined by a pyrophosphate bridge. Research published on it covers human, and 8 of the 8 studies set out below are controlled human trials. Borealis Peptides keeps it as lyophilised powder in 500 mg and 1000 mg vials for in-vitro laboratory research. It is not a medicine and is not for use in humans or animals.

What the research shows

StudyModelDose usedDurationFinding
Christen S et al.2026 · Nat Metab · PMID 41540253Human, randomised open-label placebo-controlled study (n=65, healthy adults); molecules: oral NR, NMN and nicotinamideNot stated in the abstract14 daysNR and NMN, but not nicotinamide, comparably raised circulating NAD+. Ex vivo work suggested NR and NMN are converted by gut microbes to nicotinic acid, which then raises NAD+.
Pencina KM et al.2023 · J Clin Endocrinol Metab · PMID 36740954Human, randomised controlled trial (n=30, overweight or obese adults aged 45+); molecule: oral NMN (MIB-626 tablets)Two 500 mg NMN tablets twice daily28 daysNMN substantially raised circulating NAD+ and its metabolites. Body weight (−1.9 kg), diastolic blood pressure, total and LDL cholesterol fell more than with placebo; muscle strength, aerobic capacity, insulin sensitivity and liver fat did not differ.
Brakedal B et al.2022 · Cell Metab · PMID 35235774Human, randomised double-blind phase I trial (n=30, newly diagnosed Parkinson's disease); molecule: oral NR1,000 mg NR30 daysNR was well tolerated and gave a significant but variable rise in brain NAD measured by 31P-MRS, altered cerebral metabolism on FDG-PET in those whose brain NAD rose, and lowered inflammatory cytokines in serum and cerebrospinal fluid.
Elhassan YS et al.2019 · Cell Rep · PMID 31412242Human, randomised double-blind crossover trial (n=12, aged men); molecule: oral NR1 g NR per day21 daysNR raised the skeletal muscle NAD+ metabolome and lowered circulating inflammatory cytokines, without altering mitochondrial bioenergetics.
Vreones M et al.2023 · Aging Cell · PMID 36515353Human, randomised placebo-controlled crossover trial (n=22, healthy older adults); molecule: oral NR500 mg NR twice a day6 weeksNR increased NAD+ in plasma extracellular vesicles enriched for neuronal origin and lowered their levels of Aβ42, pJNK and pERK1/2.
Katayoshi T et al.2023 · Sci Rep · PMID 36797393Human, randomised double-blind placebo-controlled trial (n=36, healthy middle-aged adults); molecule: oral NMN125 mg NMN capsule twice a day (250 mg/day)12 weeksSerum nicotinamide rose in the NMN group. Pulse wave velocity tended to fall but did not differ significantly from placebo; no adverse events were reported.
Martens CR et al.2018 · Nat Commun · PMID 29599478Human, randomised double-blind placebo-controlled crossover trial (healthy middle-aged and older adults; n not stated in the abstract); molecule: oral NRNot stated in the abstract2 × 6 weeksChronic NR was well tolerated and stimulated NAD+ metabolism; the authors suggest blood pressure and arterial stiffness as outcomes for future trials.
Castro-Marrero J et al.2021 · Nutrients · PMID 34444817Human, randomised double-blind placebo-controlled trial (n=207, ME/CFS); molecule: oral NADH combined with CoQ1020 mg NADH plus 200 mg CoQ10 once daily12 weeksWithin the treatment group, cognitive fatigue and overall FIS-40 score fell and quality of life improved from baseline; the effect of NADH cannot be separated from that of CoQ10.

What these studies don't show: The controlled evidence is genuine but tied to a particular setting. Who took part, what was measured and over what period all limit what the results can mean. None of it applies beyond the trial protocol itself. Testing establishes identity and purity; it is not evidence of an effect.

Every study links to its PubMed record. See all NAD+ studies in the research library →

NAD+ price in Canada: 500mg and 1g vials

Buy NAD+ in Canada in 2 vial sizes and a starter kit. Prices are in Canadian dollars, you pay by Interac e-Transfer or bank transfer, and orders are shipped from Canadian stock.

SizePricePer mg
500 mg$46.50$0.09/mg
1 g$76.00$0.08/mg

Starter kit

Is NAD+ available in Canada?

NAD+ is not listed in the Drug Product Database as an authorized product. No regulator here has reviewed its safety, efficacy or quality. Borealis Peptides holds it purely for in-vitro research and provides it for use in no living subject. How Health Canada treats research peptides →

Side effects reported in studies

Every statement is bound to the study that reported it. Tolerability observations from the cited papers appear below in the authors own terms. Human research on this scale cannot establish a safety profile. Read more →

Doses used in studies

Read more →

NAD+ FAQ

What is NAD+?

Both suppliers and the literature list NAD+ as a redox coenzyme (dinucleotide), not a peptide. Research reported on it covers human. Borealis Peptides keeps it as lyophilised powder in 500 mg and 1000 mg vials for in-vitro laboratory research. None of it is a medicine; it is not for human or veterinary use. The table on this page sets out each study, its model and its reported result.

Where can I buy NAD+ in Canada?

Straight from Borealis Peptides, kept in Canadian stock so nothing crosses a border on the way to you. Held in 500 mg and 1000 mg vials. Purity is confirmed by HPLC batch by batch, and we supply for laboratory research only.

Is NAD+ legal in Canada?

NAD+ is not listed in the Drug Product Database as an authorized product. No regulator here has reviewed its safety, efficacy or quality. In-vitro research is what Borealis Peptides keeps it for; it is supplied for use in no living subject. Because Health Canada has stated that "Research Use Only" labelling does not make a product legal to use in a person, we take it to describe what the material is supplied for and grant no permission by it.

How much NAD+ should I use?

We do not field dosing questions. NAD+ is not supplied for use in a person or an animal, so there is no dose to describe. What this page carries is the quantity each cited study used and the model it was used in, reproduced as the authors published it.

What human evidence is there for NAD+?

Among the 8 cited studies, 8 are controlled human trials and the remainder are animal or cell work. Every row states its model, the quantity used and what the authors reported, letting each study be weighed directly rather than via a summary.

How is NAD+ stored?

The dry powder sits at −20 °C, kept away from light. Once reconstituted, 2–8 °C once in solution. Since the dry form holds up at room temperature, shipping needs no cold chain; refrigerate it on arrival. A lyophilised peptide is degraded by light and temperature cycling, not by how long it spends in transit.

How is the purity of NAD+ confirmed?

HPLC testing is done on every batch before sale, and the certificate points to the batch in your vial rather than to the product in general. Filing that batch number with your records is what lets an observation be reproduced later. Certificates can be requested at any time.

How does NAD+ compare with MOTS-C and SS-31?

These are distinct compounds with distinct published records, and this site does not rank them. MOTS-C and SS-31 carry 7 cited studies and 7 cited studies on their page against 8 here. The useful comparison lies between the two study tables and the models behind them.

Compare with